Resources
If you cannot find the content you need here, please contact us.
BOA 2022 Congress and London Knee Meeting Summary
We attended the BOA2022 Congress and London Knee Meeting this month to introduce Arthrosamid®, a new class of therapy for patients with knee osteoarthritis. the coming month, we will attend the Bristol/Oxford Uni Knee Meeting and Wexham Cruciate 2022.
BASK 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA
Safe and sustained pain relief with a single injection. A novel treatment for adults with knee osteoarthritis.
BASK 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA
ESSKA 2022 - Introducing Arthrosamid®, a new class of injectable therapy to treat knee OA
BOA 2021 - Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making
Contura Orthopaedics Sponsored Session at BOA 2021 - Presentation on Arthrosamid® by Contura Orthopaedics Ltd - The Knee OA Treatment 20 Years in the Making - Whole Presentation
Dr Ieva Ankorina Stark Hydrogel BOA 2021
Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information
Prof Henning Bliddal BOA 2021
Contura Sponsored Session at BOA 2021 - Presentation on Arthrosamid Novel OA Treatment Clinical Results
Prof Phil Conaghan OARSI 2021
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Introduction on Intraarticular OA treatments
OARSI 2021 Emerging data on a new class of knee OA therapy
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Whole Presentation
Dr Ieva Ankorina Stark Hydrogel OARSI 2021
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment - Product Information
Prof Henning Bliddal OARSI 2021
Contura Sponsored Session at OARSI Connect 2021 - Presentation on Arthrosamid Novel OA Treatment Clinical Results